| Breathing Focused Yoga in Social Anxiety Disorder (NCT02266680) | Centre for Addiction and Mental Health | 2012-01-01 |
| Treatment Study for Rural Latino Youth With Anxiety (NCT01491880) | University of California, San Diego | 2011-11-01 |
| Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children (NCT01687764) | Hospital de Clinicas de Porto Alegre | 2011-08-01 |
| 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder (NCT01316302) | The Medical Research Network | 2011-04-01 |
| Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder (NCT02036658) | Stanford University | 2011-03-01 |
| CBT for Social Anxiety Disorder Delivered by School Counselors (NCT01320800) | NYU Langone Health | 2010-10-01 |
| False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders (NCT02082561) | Florida State University | 2010-07-01 |
| Five Year Follow-up of Internet-based Cognitive Behaviour Therapy (CBT) for Social Anxiety Disorder (SAD) (NCT01145690) | Karolinska Institutet | 2010-06-01 |
| Variations of Cognitive Behavior Therapy for Social Anxiety Disorder (NCT00948974) | Drexel University | 2010-01-01 |
| Escitalopram in Patients With Social Anxiety Disorder (NCT00902226) | H. Lundbeck A/S | 2009-03-01 |
| Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety (NCT00958880) | Southern Methodist University | 2009-03-01 |
| Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting (NCT00862212) | Medical University of South Carolina | 2009-01-01 |
| Flushing in Social Anxiety Disorder on Cipralex (NCT00485888) | START Clinic for Mood and Anxiety Disorders | 2008-10-01 |
| An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia (NCT00485615) | START Clinic for Mood and Anxiety Disorders | 2008-10-01 |
| The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels (NCT01385709) | Weill Medical College of Cornell University | 2008-08-01 |
| Quetiapine in Co-Morbid Depressive and Anxiety Disorders (NCT00688818) | Centre for Addiction and Mental Health | 2008-06-01 |
| A Systems Level Intervention for Unemployed Persons With Social Anxiety Disorder (NCT01654510) | University of Michigan | 2008-04-01 |
| Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia (NCT01217788) | Pherin Pharmaceuticals, Inc. | 2008-02-01 |
| An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR) (NCT00606541) | Duke University | 2008-01-01 |
| Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia (NCT00515879) | Boston University Charles River Campus | 2007-12-01 |
| Interpretation Modification Program for Social Phobia (NCT00684541) | San Diego State University | 2007-09-01 |
| D-Cycloserine Enhancement of Exposure in Social Phobia (NCT00633984) | Massachusetts General Hospital | 2007-03-01 |
| Attention Disengagement Training for Social Phobia (NCT00684320) | San Diego State University | 2006-09-01 |
| Primary Care Intervention Strategy for Anxiety Disorders (NCT00347269) | University of Washington | 2006-06-01 |
| Efficacy of Quetiapine in Generalised Social Anxiety Disorder (NCT00302770) | AstraZeneca | 2006-06-01 |
| Acamprosate in Alcoholics With Comorbid Anxiety or Depression (NCT00330174) | Medical University of South Carolina | 2006-04-01 |
| Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults (NCT01224067) | Cambridge Health Alliance | 2006-03-01 |
| fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder (NCT00332046) | GlaxoSmithKline | 2006-01-01 |
| A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder (NCT00273039) | GlaxoSmithKline | 2005-08-01 |
| Virtual Reality Exposure Therapy for the Treatment of Social Phobia (NCT02379949) | Georgia State University | 2004-08-01 |
| Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety (NCT00177008) | University of Medicine and Dentistry of New Jersey | 2004-03-01 |
| Quetiapine in Social Anxiety Disorder (NCT00215254) | Duke University | 2004-03-01 |
| Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder (NCT00074802) | Temple University | 2003-12-01 |
| Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism (NCT00246441) | Medical University of South Carolina | 2002-03-01 |
| Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder (NCT00238719) | Wyeth is now a wholly owned subsidiary of Pfizer | 1999-12-01 |